chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event.  The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMh significant for CAD, AF, aortic valve stenosis, advanced age. Moved into ALF in March 2021. No 2nd dose of moderna covid vaccine documented, pt choose not to receive it. Wife called 4/22/2021 to report death but did not say exactly when date of death was. No cause of death or other recent illness noted.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:  Admitted to hospital 4/23/21
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death, Resuscitation, Ventricular fibrillation
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has PMH significant for t2dm, hyperlipidemia, htn, lipoma, cad, vitamin d deficiency. Patient received 2nd dose of moderna on 4/20/2021 and presented to a local emergency room on 4/28. Per note on 4/28, pt had a chief complaint of cardiac arrest/ ventricular fibrillation with cpr in progress. There is no other note regarding death or cause of death noted. Pt was 61 Years of age.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dry throat, Thirst
Clinical narrative: Narrative:  She relates having experienced dry throat that started about 40 minutes after the initial vaccination and lasted for about 2-3 hours. During that time, she felt very thirsty (much more than normal) - causing her to drink more water than normal. The increase in water intake a/w feelings of dry throat. She did not have difficulty drinking water/eating. She denied difficulty breathing or swallowing itchiness, urticaria, flushing, swelling of any part of body including face, confusion/disorientation, dizziness/lightheadedness, weakness, shortness of breath, palpitations, nausea, abdominal cramping, or feeling the need to vomit/have diarrhea.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Diarrhoea, Fatigue, Injection site pain
Clinical narrative: Narrative:  67 yo F, received dose #1 of the Moderna COVID-19 vaccine on 03/20/2021 (Lot#: 038A21A; Exp Date: 09/02/2021) and dose #2 of the Moderna COVID-19 vaccine on 04/17/2021 (Lot#: 037B21A; Exp Date: 10/01/2021). Patient reports systemic symptoms including diarrhea, chills, malaise, fatigue, loss of appetite, and rash (with first dose only) ongoing for roughly four weeks following administration of dose #1 on 3/20/2021. Questionable allergic reaction including rash, pruritus, and pain at injection site. Patient was advised to treat with OTC pain relievers including NSAIDs and antihistamines. Reaction classified as moderate as intervention required.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pruritus, Rash
Clinical narrative: Narrative:  67 yo F, received dose #1 of the Moderna COVID-19 vaccine on 03/20/2021 (Lot#: 038A21A; Exp Date: 09/02/2021) and dose #2 of the Moderna COVID-19 vaccine on 04/17/2021 (Lot#: 037B21A; Exp Date: 10/01/2021). Patient reports systemic symptoms including diarrhea, chills, malaise, fatigue, loss of appetite, and rash (with first dose only) ongoing for roughly four weeks following administration of dose #1 on 3/20/2021. Questionable allergic reaction including rash, pruritus, and pain at injection site. Patient was advised to treat with OTC pain relievers including NSAIDs and antihistamines. Reaction classified as moderate as intervention required.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Narrative:  Patient contracted covid infection 7 days after receiving covid vaccine dose #1. Pt was treated at private sector hospital with BAM-EUA . Pt was instructed to wait 90 days before receiving covid vaccine dose #2. Pt received the dose#2 on 4/30/21. This is when the patient reported this information.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram head abnormal, Magnetic resonance imaging abnormal
Clinical narrative: Narrative:
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Narrative:  He relates having experienced nausea that started while he was driving home from the initial vaccination. When he got home, he took a zofran (already had on-hand) and ate lunch. The nausea lasted for about 30 minutes. He denied other common adverse effects including vomiting, diarrhea, and abdominal cramping. He was able to tolerate lunch w/o any issues.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Ammonia increased, Bronchitis, Cough, Death
Clinical narrative: Narrative:  Patient received COVID vaccine #1 on 2/26/21 and #2 on 3/26/21. On 4/6/21, he presented to primary care with c/o dizziness, fever, shortness of breath, productive cough, lower extremity swelling and abdominal swelling. One week prior to this he was also seen at urgent care for cough and fever and diagnosed with bronchitis and given azithromycin. He was sent from primary care to the ER. It is also noted he had an elevated ammonia level of 62.3 (history of end stage liver disease). He was evaluated in the ER and admitted to acute care services for a LLL pneumonia. He received ceftriaxone 1gm daily, Duonebs q6h and azithromycin 500mg po daily. On 4/9/21, he was discharged home with his wife on amoxicillin 500mg bid and azithromycin 500mg po daily. On 4/11/21, it was reported that he had passed away. Of note on 4/6/21, his COVID test, flu A &B and RSV test was negative and on 4/7/21, a Biofire was done that was negative also. 16 days from date of second vaccine to date of death.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Influenza A virus test negative, Influenza B virus test, Peripheral swelling
Clinical narrative: Narrative:  Patient received COVID vaccine #1 on 2/26/21 and #2 on 3/26/21. On 4/6/21, he presented to primary care with c/o dizziness, fever, shortness of breath, productive cough, lower extremity swelling and abdominal swelling. One week prior to this he was also seen at urgent care for cough and fever and diagnosed with bronchitis and given azithromycin. He was sent from primary care to the ER. It is also noted he had an elevated ammonia level of 62.3 (history of end stage liver disease). He was evaluated in the ER and admitted to acute care services for a LLL pneumonia. He received ceftriaxone 1gm daily, Duonebs q6h and azithromycin 500mg po daily. On 4/9/21, he was discharged home with his wife on amoxicillin 500mg bid and azithromycin 500mg po daily. On 4/11/21, it was reported that he had passed away. Of note on 4/6/21, his COVID test, flu A &B and RSV test was negative and on 4/7/21, a Biofire was done that was negative also. 16 days from date of second vaccine to date of death.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pneumonia, Productive cough, Pyrexia, Respiratory syncytial virus test negative, SARS-CoV-2 test negative
Clinical narrative: Narrative:  Patient received COVID vaccine #1 on 2/26/21 and #2 on 3/26/21. On 4/6/21, he presented to primary care with c/o dizziness, fever, shortness of breath, productive cough, lower extremity swelling and abdominal swelling. One week prior to this he was also seen at urgent care for cough and fever and diagnosed with bronchitis and given azithromycin. He was sent from primary care to the ER. It is also noted he had an elevated ammonia level of 62.3 (history of end stage liver disease). He was evaluated in the ER and admitted to acute care services for a LLL pneumonia. He received ceftriaxone 1gm daily, Duonebs q6h and azithromycin 500mg po daily. On 4/9/21, he was discharged home with his wife on amoxicillin 500mg bid and azithromycin 500mg po daily. On 4/11/21, it was reported that he had passed away. Of note on 4/6/21, his COVID test, flu A &B and RSV test was negative and on 4/7/21, a Biofire was done that was negative also. 16 days from date of second vaccine to date of death.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Fibrin D dimer, Peripheral swelling
Clinical narrative: Narrative:  86 y/o Moderna shot #2 on 3/9; couple weeks later leg swelling; 04/13 DVT dx 86 y/o HTN/DM Apr 14, 2021 Test name Result units Ref. range D-DIMER 3.98 H ug/mL FEU 0.00 - 0.50 Do not believe the left leg DVT was "preventable", however, swelling of left leg did occur within 1-2 weeks after second COVID vaccine, pt waited 3 weeks to go to hospital and was diagnosed with left leg DVT
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash papular, Rash pruritic
Clinical narrative: Narrative:  Patient received first dose of Pfizer COVID19 vaccine on 2/18/21. No adverse reactions reported. Received second dose 3/11/21. Patient called clinic 4/30/21 reporting intermittent, generalized rash. Described rash as raised, reddened and itchy. Reported taking OTC diphenhydramine, dose and frequency unknown. Patient was traveling and unable to come to clinic or complete virtual visit for evaluation. Was instructed to report to local urgent care if additional care needed.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Dry mouth, Dyspnoea, Palpitations, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following completion of COVID vaccine series 01/25 COVID vaccine dose #1 02/21 COVID vaccine dose #2 05/08 COVID testing for pre-procedure for hernia surgery 05/09 patient aysmptomatic 05/10 patient reports waking up out of breath, dry mouth heart pounding, HR 33, rebounded to 53 (h/o hypotension and bradycardia); advised to go to ED if SOB
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Deep vein thrombosis, Embolism venous, Haemoglobin decreased, Platelet count
Clinical narrative: Narrative: Patient presented to clinic with PE/DVT approx. 2 weeks after receiving J&J vaccine; started on rivaroxaban for VTE treatment. Patient's Hgb noted to have declined from 14 to 11.8; platelets remaining stable. patient w/o known provoking cause, no h/o hypercoag, cancer, or FH
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Dyspnoea at rest
Clinical narrative: Narrative:  Patient received Moderna COVID vaccine #1 on 2/8/21 and #2 on 3/8/21. On 3/9/21, he had an appointment with pulmonology due to history of severe idiopathic pulmonary fibrosis that was worsening and he had c/o dyspnea even at rest. After discussion with provider, a hospice consult was placed. It was completed on 3/12/21 and per notes, he met hospice criteria, but declined for community hospice at that time. No further notes entered and a date of death was recorded as 4/4/21. No autopsy report available. Time from vaccine #2 and date of death is 27 days.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMh significant for CKD, Glaucoma, bradycardia, vitamin d deficiency, hyperlipidemia, basal cell carcinoma of skin, peripheral vascular disease. Diabetes Mellitus. Carotid Artery stenosis, HTN, advanced age. Per note, patient deceased on 5/3/2021. No cause of death noted.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Electrocardiogram, Rash, Throat tightness, Troponin
Clinical narrative: Narrative: Patient received first dose of COVID-19 vaccine at the facility on 2/23/2021, started to complain of chest pain and throat tightness and a rash on his trunk and sent to facility. Facility gave patient IV methylprednisolone, IV famotidine and IV diphenhydramine and recommended patient go to ED. ED completed repeat EKG and troponin given patients symptoms were improving, ED discharged patient home with a 5 day course of prednisone 60 mg daily and a 7 day course of diphenhydramine 25 mg three times daily.
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMh significant for htn, af, aflutter, primary malignant neoplasm of penis. Pt was 96 years of age. No cause of death noted, or recent hospitalizations noted.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Dyspnoea, Oxygen saturation abnormal, Rash, Swelling
Clinical narrative: Narrative:  anaphylaxis following COVID-19 Moderna vaccine. no O2 desaturation, +rash, + swelling, + short of breath. Recovered well after epi- pen, diphenhydramine, and solu-medrol. Sent home with prednisone taperr
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Knee arthroplasty, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID INFECTION AFTER COMPLETION OF COVID VACCINE SERIES 01/28 COVID vaccine dose #1 02/18 COVID vaccine dose #2 05/08 COVID testing for pre-op for TKA, COVID positive, reports being around coworkers that were known or suspected positive; no symptoms
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Hypoxia, Pneumonia bacterial
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH include chronic A.Fib, Hypertension, Hyperlipidemia, DM-II, Asthma, Anemia, Angina, Osteoarthritis, Pulmonary Fibrosis, Depression, respiratory failure, CKD, angina, vitamin d deficiency. Pt was 91 years of age.. Patient came to hospital on 4/17 with a cc of sob and found to be hypoxic. Diagnosed with bacterial pneumonia. placed on hospice on 4/21.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Narrative:  5/3 patient spoke to PCP who instructed patient to continue  w/Hydrocortisone cream and could also try Loratadine as needed. Patient to follow up if gets worse, but per note was improving.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Narrative:  Patient was administered an expired dose of the Janssen Vaccine (expiration date 5/10/2021 @1730 and administration date 5/11/2021 @8:53). Company was contacted and it was determined that the course of action was for the patient to receive another dose of the Janssen Vaccine in the opposite arm. Patient was contacted, briefed on situation, and agreed to receive another Janssen vaccine (5/11/2021 @10:14). JPSR event was entered to review a "system-based" solution and PCP alerted.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Death, Dyspnoea
Clinical narrative: Narrative: PFIZER-BIONTECH COVID-19 VACCINE EUA 74 YEAR OLD PATIENT RECEIVED PFIZER COVID-19 DOSE #1 ON 2/6/2021 AND DOSE #2 3/8/2021. WAS ADMITTED TO A OUTSIDE HOSPITAL ON 4/17/2021 DUE TO COVID-19 INFECTION AND PNEUMONIA, DISCHARGED 4/21/2021. WIFE STATED THE ENTIRE FAMILY HAD COVID-19. PATIENT READMITTED ON 4/23/2021 TO ANOTHER HOSPITAL WITH WORSENING O2 SAT AND DIFICULTY BREATHING. ADMITTING DIAGNOSIS: ACUTE HYPOXIC REPIRATORY FAILURE, WORSENING COVID PNEUMONIA VS. BACTERIAL PNEUMONIA. TRANSFERRED TO ICU AND INTUBATED ON 4/28/21. TREATED WITH COVID-DIRECTED THERAPY WITH REMDESIVIR AND DEXAMETHASONE, PRESSOR SUPPORT, PRONE, ETC. CLINICAL STATUS CONTINUED TO WORSEN AND UNABLE TO BE WEANED OFF VENTILATOR. PALLIATIVE CARE TEAM MET WITH FAMILY AND PATIENT TRANSITIONED TO COMFORT CARE AND EXPIRED THE NEXT DAY.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, General physical health deterioration, Intensive care, Mechanical ventilation, Pneumonia
Clinical narrative: Narrative: PFIZER-BIONTECH COVID-19 VACCINE EUA 74 YEAR OLD PATIENT RECEIVED PFIZER COVID-19 DOSE #1 ON 2/6/2021 AND DOSE #2 3/8/2021. WAS ADMITTED TO A OUTSIDE HOSPITAL ON 4/17/2021 DUE TO COVID-19 INFECTION AND PNEUMONIA, DISCHARGED 4/21/2021. WIFE STATED THE ENTIRE FAMILY HAD COVID-19. PATIENT READMITTED ON 4/23/2021 TO ANOTHER HOSPITAL WITH WORSENING O2 SAT AND DIFICULTY BREATHING. ADMITTING DIAGNOSIS: ACUTE HYPOXIC REPIRATORY FAILURE, WORSENING COVID PNEUMONIA VS. BACTERIAL PNEUMONIA. TRANSFERRED TO ICU AND INTUBATED ON 4/28/21. TREATED WITH COVID-DIRECTED THERAPY WITH REMDESIVIR AND DEXAMETHASONE, PRESSOR SUPPORT, PRONE, ETC. CLINICAL STATUS CONTINUED TO WORSEN AND UNABLE TO BE WEANED OFF VENTILATOR. PALLIATIVE CARE TEAM MET WITH FAMILY AND PATIENT TRANSITIONED TO COMFORT CARE AND EXPIRED THE NEXT DAY.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia bacterial, Weaning failure
Clinical narrative: Narrative: PFIZER-BIONTECH COVID-19 VACCINE EUA 74 YEAR OLD PATIENT RECEIVED PFIZER COVID-19 DOSE #1 ON 2/6/2021 AND DOSE #2 3/8/2021. WAS ADMITTED TO A OUTSIDE HOSPITAL ON 4/17/2021 DUE TO COVID-19 INFECTION AND PNEUMONIA, DISCHARGED 4/21/2021. WIFE STATED THE ENTIRE FAMILY HAD COVID-19. PATIENT READMITTED ON 4/23/2021 TO ANOTHER HOSPITAL WITH WORSENING O2 SAT AND DIFICULTY BREATHING. ADMITTING DIAGNOSIS: ACUTE HYPOXIC REPIRATORY FAILURE, WORSENING COVID PNEUMONIA VS. BACTERIAL PNEUMONIA. TRANSFERRED TO ICU AND INTUBATED ON 4/28/21. TREATED WITH COVID-DIRECTED THERAPY WITH REMDESIVIR AND DEXAMETHASONE, PRESSOR SUPPORT, PRONE, ETC. CLINICAL STATUS CONTINUED TO WORSEN AND UNABLE TO BE WEANED OFF VENTILATOR. PALLIATIVE CARE TEAM MET WITH FAMILY AND PATIENT TRANSITIONED TO COMFORT CARE AND EXPIRED THE NEXT DAY.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Ejection fraction decreased, Hypotension, Intensive care, Peripheral swelling
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt was 90 years of age, with a PMH significant for HF, AF, DM, vitamin d deficiency, neoplasm of skin, obesity, hyperlipidemia. Pt was previous admitted for worsening leg swelling. EF less than 20%. Hypotensive, and transferred to SDU on 3/29. Transferred to micu on 4/2. Transferred to hospice care on 4/3.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Incomplete course of vaccination
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 95 years of age and did not receive 2nd dose of vaccine. elected hospice service on 3/9/21. Medically unable to get 2nd dose, declined per wife and not interested. PMH significant for hyperlipidemia, cerebral infarction, htn, CAD, CKD, squamous cell carcinoma, COPD, malignant melanoma of scalp.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose normal, Electrocardiogram normal, Palpitations
Clinical narrative: Narrative:  Patient with PMH of Type 2 diabetes diagnosed, HTN, and history of HPV received 2nd dose of COVID vaccine series on 4/10/21 and reported symptoms of palpitations and "heart racing" shortly after administration. Vital signs and blood glucose measured during observation after receiving 2nd dose were within normal limits, and patient was given orange juice and water since she reported not eating breakfast or taking medications prior to receiving the vaccine. Patient requested to go to the ED given reported family history of heart disease. Bedside EKG monitoring in ED was normal and patient was asymptomatic at time of leaving ED.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Narrative:  Patient received 1st Pfizer COVID-19 vaccine on 3/16/21 and 2nd  dose on 3/30/21. [14 day interval between doses.] The interval between Pfizer doses in 21 days (However, 2nd doses administered within a grace period of 4 days earlier than the recommended date for the 2nd dose are still considered valid) Per guide for use of COVID-19 Vaccines (Recommendations for COVID-19 vaccine administration errors and deviations), Do not repeat dose if second dose administered fewer than 17 days (Pfizer-BioNTech) after first dose.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for congestive cardiomyopathy, COPD, paronychia, HTN, Diabetes, tobacco use, vitamin d deficiency, mantoux positive, cocaine abuse. proteinuria, anemia. Per note, patient passed away in home 5/3. No cause of death noted.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Dyspnoea, Dyspnoea exertional, Orthopnoea
Clinical narrative: Narrative: Patient was hospitalized from 2/3/21-2/12/21 with new onset CHF and received COVID vaccine on 2/12. Patient states SOB seemed to worsen and is worse when lying down or with exertion and was wondering if it was due to  vaccine. Followed up with PCP and orthopnea/dyspnea on exertion is likely due to CHF
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:  lessened with antuihist H1 and H2 blockers
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Cellulitis, Hypersensitivity, Pruritus, Rash, Rash erythematous
Clinical narrative: Narrative:  Patient received first dose of Pfizer COVID19 vaccine 5/3/21 and presented to ED 5/9/21 with rash. Reported itching and painful rash starting ~24 hours after receiving vaccine. Per nursing notes, red and swollen bumps observed on patient's bilateral legs, face, and right arm. Given prednisone, famotidine and diphenhydramine in ED. Diagnosed with allergic reaction and cellulitis by ED MD. Discharged from ED with doxycycline and prednisone outpatient prescriptions.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Narrative:  Patient received first dose of Pfizer COVID19 vaccine 5/3/21 and presented to ED 5/9/21 with rash. Reported itching and painful rash starting ~24 hours after receiving vaccine. Per nursing notes, red and swollen bumps observed on patient's bilateral legs, face, and right arm. Given prednisone, famotidine and diphenhydramine in ED. Diagnosed with allergic reaction and cellulitis by ED MD. Discharged from ED with doxycycline and prednisone outpatient prescriptions.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Fall
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMh significant for nephrogenic diabetes insipidus, cancer of esophagus, prostate cancer, parkinson's disease, dementia, anemia, obstructive sleep apnea, hyperlipidemia, diabetes mellitus, htn, bipolar. Was seen at ER on 4/9 with cc of SOB x 1 week and discharged. Pt fell on 4/21 but not injured. Pt was 72 years of age and deceased on 5/1/2021. No cause of death noted.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Glossitis, Glossodynia
Clinical narrative: Narrative:  Patient recieved 2nd COVID-19 vaccine (Pfizer) on 3/2/21. About one month later, lost sense of taste and complained of tongue pain when eating spicy foods. Was seen by dentist, dentist dx his tongue with inflamed papilla. PCP treated with bethametsone cream. Sx have not resolved as of this reporting.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Death, Diarrhoea, Fatigue
Clinical narrative: Narrative: Patient did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for squamous cell carcinoma, t2dm, copd, CAD, pulmonary nodule. Per note on 4/20 Patient received #1 Moderna vaccine on 4/14. Wife said that the following day he started having side effects of productive cough, fatigue, chills, headache, nausea, and diarrhea. However, last night wife said that her husband started coughing up blood and hyperventilating. Patient was admitted to hospital with diagnosis of moderate case of Covid with probable exposure prior to vaccination. Wife said that church had several cases and had recently close so feel he was exposed while in attendance. Patient wife said that treating with steroids, breathing treatments, and currently on O2 6L. Patient received care for covid-19 at outside facility on 4/20. Patient deceased 4/22 but no cause of death was documented. Patient got covid before he could build a immune response to his first dose of moderna.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoptysis, Headache, Hyperventilation, Nausea, Productive cough
Clinical narrative: Narrative: Patient did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for squamous cell carcinoma, t2dm, copd, CAD, pulmonary nodule. Per note on 4/20 Patient received #1 Moderna vaccine on 4/14. Wife said that the following day he started having side effects of productive cough, fatigue, chills, headache, nausea, and diarrhea. However, last night wife said that her husband started coughing up blood and hyperventilating. Patient was admitted to hospital with diagnosis of moderate case of Covid with probable exposure prior to vaccination. Wife said that church had several cases and had recently close so feel he was exposed while in attendance. Patient wife said that treating with steroids, breathing treatments, and currently on O2 6L. Patient received care for covid-19 at outside facility on 4/20. Patient deceased 4/22 but no cause of death was documented. Patient got covid before he could build a immune response to his first dose of moderna.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Narrative:  PATIENT REPORTS LEFT LEG SWELLING SINCE VACCINE ON 4/21/21 TO CURRENT.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Drooling, Electroencephalogram abnormal, Eye movement disorder, Seizure, Temporal lobe epilepsy
Clinical narrative: Narrative:  Patient reports he had seizure 2 days after receiving COVID vaccine. Patient's friend who witness the seizure states he was shaking, drooling, and eyes were rolled up, seizure lasted 20 minutes, which occurred while he was asleep. Patient followed up with neurology and EEG shows left temporal epileptiform discharged and was started on lamotrigine.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Narrative:  Patient reports he had seizure 2 days after receiving COVID vaccine. Patient's friend who witness the seizure states he was shaking, drooling, and eyes were rolled up, seizure lasted 20 minutes, which occurred while he was asleep. Patient followed up with neurology and EEG shows left temporal epileptiform discharged and was started on lamotrigine.
Age: 103.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Details of death not documented in chart but note from 2/25/21 mentions patient was in hospice care. Patient was 101 yo with comorbidities including COPD, CAD, DM, CKD, pacemaker, hypothyroidism, HTN, HLD
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: Incidental COVID-19 positive test on admission 5/7/21, asymptomatic.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Fall, Vertigo
Clinical narrative: Narrative: Patient experienced Vertigo 20 days after vaccination dose #1. 03/29 COVID vaccine dose #1 04/19 Pt seen in non ED due to dizziness "head is spinning, falling and off balance, " treated with rx for meclizine 25mg tid 04/26 COVID vaccine dose #2 05/07 Pt seen by PCP; noted in record: "pt developed vertigo right after both COVID shots...reactions resolved."
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Discomfort, Hypersensitivity, Hypoaesthesia, Joint stiffness
Clinical narrative: Narrative: 40 YO female who received the 1st dose of COVID-19 vaccine on 3/21/21 and 2nd dose on 4/11/21. Patient reported symptoms to her primary care provider and ID consult was placed. She reported sore arm x2 days, then severe joint pain and stiffness in knees, wrist, and axillary region x5 days. She reports the pain being severe and taking ibuprofen 800 mg daily. At most recent follow-up on 5/5/21, knee pain has resolved but hands and wrists continue to feel tight and  stiff. She also reported a heavy feeling in her sinuses with hypersensitivity in right cheek and numbness in left cheek, which still persisted at follow-up. Per ID consult, no current data supporting association between COVID vaccines and reactive arthritis or facial symptoms. Patient is currently being worked up for  other causes (neurology, arthritis, inflammatory markers, X-rays).
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Malaise, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Narrative: 40 YO female who received the 1st dose of COVID-19 vaccine on 3/21/21 and 2nd dose on 4/11/21. Patient reported symptoms to her primary care provider and ID consult was placed. She reported sore arm x2 days, then severe joint pain and stiffness in knees, wrist, and axillary region x5 days. She reports the pain being severe and taking ibuprofen 800 mg daily. At most recent follow-up on 5/5/21, knee pain has resolved but hands and wrists continue to feel tight and  stiff. She also reported a heavy feeling in her sinuses with hypersensitivity in right cheek and numbness in left cheek, which still persisted at follow-up. Per ID consult, no current data supporting association between COVID vaccines and reactive arthritis or facial symptoms. Patient is currently being worked up for  other causes (neurology, arthritis, inflammatory markers, X-rays).
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Headache
Clinical narrative: Narrative: Patient received COVID vaccine on 1/28/2021, and reports diarrhea and headache on 2/2/ for x3 days. Denies fever, rash, swelling, cough, SOB
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Nausea, Restlessness
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for Red cell aplasia, hyperlipidemia, t2dm, HTN, angioimmunoblastic t-cell lymphoma, chronic hypoxemic respiratory failure. Pt presented to outside facility with cc of increased SOB and dyspnea on 4/21, was dc 4/27. On may 6th per note, wife reported that patient felt nauseous and restless. Patient deceased 5/6 at 1349.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash papular, Rash pruritic, Skin texture abnormal
Clinical narrative: Narrative:  It was reported that rash appeared in small area within hours after vaccination and spread slowly that evening. By the next day, rash was all over the entire body including face, back, upper and lower body. Rash reported as red, itchy, raised with rough texture. Rash was treated with diphenhydramine oral tabs and topical cream for 1 week. Rash completely resolved after 1 week of treatment. No additional appearance of rash.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure, Chest discomfort, Chest pain, Condition aggravated, Death
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMG significant for Aortic systolic HF, paraoxysmal AF, dementia, acute diastolic HF, HTN, obesity, hyperlipidemia. Patient appeared at ER on 2/28/2021 with CC of SOB x 2 days. Discharged 3/2. Presented to ER 4/6 to ER. Per note on 5/6 "states that he was in his baseline state of health until January when he began experiencing a progressive decline in functional status. At baseline he was able to do all his iADLs and go for short walks in front of his house. Over the last 4 months he has had 5 admissions for worsening chest pain with exertion and worsening dyspnea with exertion managed usually as decompensated heart failure. His wife states that his DOE has progressed to the point where she is now bathing him and brushing his teeth frequently because he is too short of breath to do that. He additionally notes worsening chest pain with exertion and is having some chest discomfort with minimal exertion. During his current admission he has been treated with broad spectrum antibiotics for possible pneumonia and septic shock. He was originally bolused with IVF and then had attempted diuresis which was stopped due to collapsible IVC on bedside TTE. He was weaned of pressors and ultimately transferred to the floor yesterday. He does not note any fevers/chills/sweats/dysuria/diarrhea/productive cough leading up to his presentation. He has not had any recent surgery/invasive procedures/dental work" Patient deceased 5/7/2021.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Diuretic therapy, Dyspnoea, Dyspnoea exertional, Echocardiogram abnormal, General physical health deterioration
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMG significant for Aortic systolic HF, paraoxysmal AF, dementia, acute diastolic HF, HTN, obesity, hyperlipidemia. Patient appeared at ER on 2/28/2021 with CC of SOB x 2 days. Discharged 3/2. Presented to ER 4/6 to ER. Per note on 5/6 "states that he was in his baseline state of health until January when he began experiencing a progressive decline in functional status. At baseline he was able to do all his iADLs and go for short walks in front of his house. Over the last 4 months he has had 5 admissions for worsening chest pain with exertion and worsening dyspnea with exertion managed usually as decompensated heart failure. His wife states that his DOE has progressed to the point where she is now bathing him and brushing his teeth frequently because he is too short of breath to do that. He additionally notes worsening chest pain with exertion and is having some chest discomfort with minimal exertion. During his current admission he has been treated with broad spectrum antibiotics for possible pneumonia and septic shock. He was originally bolused with IVF and then had attempted diuresis which was stopped due to collapsible IVC on bedside TTE. He was weaned of pressors and ultimately transferred to the floor yesterday. He does not note any fevers/chills/sweats/dysuria/diarrhea/productive cough leading up to his presentation. He has not had any recent surgery/invasive procedures/dental work" Patient deceased 5/7/2021.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Impaired self-care
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMG significant for Aortic systolic HF, paraoxysmal AF, dementia, acute diastolic HF, HTN, obesity, hyperlipidemia. Patient appeared at ER on 2/28/2021 with CC of SOB x 2 days. Discharged 3/2. Presented to ER 4/6 to ER. Per note on 5/6 "states that he was in his baseline state of health until January when he began experiencing a progressive decline in functional status. At baseline he was able to do all his iADLs and go for short walks in front of his house. Over the last 4 months he has had 5 admissions for worsening chest pain with exertion and worsening dyspnea with exertion managed usually as decompensated heart failure. His wife states that his DOE has progressed to the point where she is now bathing him and brushing his teeth frequently because he is too short of breath to do that. He additionally notes worsening chest pain with exertion and is having some chest discomfort with minimal exertion. During his current admission he has been treated with broad spectrum antibiotics for possible pneumonia and septic shock. He was originally bolused with IVF and then had attempted diuresis which was stopped due to collapsible IVC on bedside TTE. He was weaned of pressors and ultimately transferred to the floor yesterday. He does not note any fevers/chills/sweats/dysuria/diarrhea/productive cough leading up to his presentation. He has not had any recent surgery/invasive procedures/dental work" Patient deceased 5/7/2021.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: breakthrough COVID infection requiring hospitalization
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Limb discomfort, Oedema peripheral, Peripheral swelling
Clinical narrative: Narrative: 65M reports increasing BLE swelling s/p 2nd dose COVID vaccination. Patient reports worsening swelling with associated pressure to his fingers, hands and chest wall. Intermittent SOB. Denies chest pain, BL LE edema. No treatment in ED. Furosemide at discharge.
Age: 69.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Erythema, Pain in extremity, Rash, Swelling
Clinical narrative: Narrative:  Patient received pneumonia 23 vaccination on 4/21/21 and presented to the ED with right upper arm pain, redness, swelling that occurred for 3 days after receiving PNA shot. Pt was evaluated in the ED and it was stated that the rash was cellulitis and most likely unrelated to the vaccination. Pt minor redness initially may have been from the vaccine.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Palpitations
Clinical narrative: Narrative: states experiencing left sided chest pains/palpitations and temp 100 which he took tylenol for on 2/19/21. During time of call, 15:06, Patient was not experiencing chest pain. Patient stated he will go to local ER for evaluation
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Injection site pain, Pain
Clinical narrative: Narrative: Patient received first dose of COVID-10 vaccine on 2/2/21 and Overnight, had elevated temperature of 100, body aches, injection site pain, and diarrhea. Denies SOB, swelling, chest pain, itching, redness.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Pain in extremity
Clinical narrative: Narrative:  Patient experienced body aches in which lasted the weekend, stating all joints hurt 10/10 and tender. Joints did not swell and was not red. Continues to  have left great toe pain. Denies SOB, wheezing, cough, tongue/face/lip swelling,  fever.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Bilirubin conjugated increased, Biopsy, Blood alkaline phosphatase increased
Clinical narrative: Narrative: Patient was found to have acute hepatitis by labs 13 days and by biopsy 17 days after vaccination. LTFs gradually improved. Labs for syphilis , acute viral hepatitis did not shed any light . Re-challenged with trim-sula did not cause LFTs elevation. Moderna vaccine 2nd dose was not given because of severity of initial reaction.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bilirubin increased, Blood glucose normal, Glomerular filtration rate normal, Hepatitis acute, Hepatitis viral test negative
Clinical narrative: Narrative: Patient was found to have acute hepatitis by labs 13 days and by biopsy 17 days after vaccination. LTFs gradually improved. Labs for syphilis , acute viral hepatitis did not shed any light . Re-challenged with trim-sula did not cause LFTs elevation. Moderna vaccine 2nd dose was not given because of severity of initial reaction.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test abnormal, Liver function test abnormal, Treponema test negative
Clinical narrative: Narrative: Patient was found to have acute hepatitis by labs 13 days and by biopsy 17 days after vaccination. LTFs gradually improved. Labs for syphilis , acute viral hepatitis did not shed any light . Re-challenged with trim-sula did not cause LFTs elevation. Moderna vaccine 2nd dose was not given because of severity of initial reaction.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: Narrative: .59 y/o female, post menopausal (no hormone replacement therapy). BMI=30. No personal h/o clotting. Her Father had clotting issues with cancer/chemo .She is having Factor V Leiden workup to make sure not predisposed. Patient did reports symptoms started about 3 weeks after vaccination (vaccine 3/24/21, DVT dx was 4/26/21)
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fall, Speech disorder
Clinical narrative: Narrative:  Patient received first COVID vaccine on 2/11 where he reports feeling extremely weak and having hard time with words. Patient has also been falling since he returned home. Denies facial, lip, or tongue swelling, rash, itching, chest pain. Patient was instructed to call 911.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: Narrative:  .61 y/o male with relatively benign PMH (ONLY HTN and arthritis), had 2nd COVID vaccine (Moderna) on 4/10/2021 and developed Bilateral PE AND DVT left leg 4/14/2021 (no prior history of clotting, or report of family hisotry clotting)
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was admitted to a facility on 3/29/21 with details unknown. He passed away there on 4/19/21. His comorbidities include PVD, RA, CAD, HTN, HLD, CKD, h/o coronary bypass
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Convalescent plasma transfusion, Death
Clinical narrative: Narrative:  71 yo M, received dose #1 of the Moderna COVID-19 vaccine on 3/2/2021 (Lot#: 001A21A; Exp Date: 08/16/2021). On 02/26/2021, patient reported symptoms including SOB, malaise, myalgia, nausea, hematuria, and L flank pain. Patient called health care system on 3/1/2021 to inquire if patient may receive COVId-19 vaccine when he has a UTI. On 3/2/2021, nurse documented that patient denied COVID-related symptoms. Received dose #1 Moderna COVID-19 vaccine on 3/2/2021. On 3/3/2021, patient presented to emergency department due to worsening symptoms and tested positive for COVID-19 and subsequently admitted into hospital. Patient received convalescent plasma on 3/3/2021. Throughout hospital course, patient developed acute hypoxemic respiratory failure secondary to COVID-19 pneumonia later complicated by right upper lobe PE with pulmonary hemorrhage and superimposed VAP and associated E. coli bacteremia. Reaction classified as severe as death occurred following vaccination.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Escherichia bacteraemia, Flank pain, Haematuria, Malaise
Clinical narrative: Narrative:  71 yo M, received dose #1 of the Moderna COVID-19 vaccine on 3/2/2021 (Lot#: 001A21A; Exp Date: 08/16/2021). On 02/26/2021, patient reported symptoms including SOB, malaise, myalgia, nausea, hematuria, and L flank pain. Patient called health care system on 3/1/2021 to inquire if patient may receive COVId-19 vaccine when he has a UTI. On 3/2/2021, nurse documented that patient denied COVID-related symptoms. Received dose #1 Moderna COVID-19 vaccine on 3/2/2021. On 3/3/2021, patient presented to emergency department due to worsening symptoms and tested positive for COVID-19 and subsequently admitted into hospital. Patient received convalescent plasma on 3/3/2021. Throughout hospital course, patient developed acute hypoxemic respiratory failure secondary to COVID-19 pneumonia later complicated by right upper lobe PE with pulmonary hemorrhage and superimposed VAP and associated E. coli bacteremia. Reaction classified as severe as death occurred following vaccination.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pneumonia, Pulmonary haemorrhage, SARS-CoV-2 test positive
Clinical narrative: Narrative:  71 yo M, received dose #1 of the Moderna COVID-19 vaccine on 3/2/2021 (Lot#: 001A21A; Exp Date: 08/16/2021). On 02/26/2021, patient reported symptoms including SOB, malaise, myalgia, nausea, hematuria, and L flank pain. Patient called health care system on 3/1/2021 to inquire if patient may receive COVId-19 vaccine when he has a UTI. On 3/2/2021, nurse documented that patient denied COVID-related symptoms. Received dose #1 Moderna COVID-19 vaccine on 3/2/2021. On 3/3/2021, patient presented to emergency department due to worsening symptoms and tested positive for COVID-19 and subsequently admitted into hospital. Patient received convalescent plasma on 3/3/2021. Throughout hospital course, patient developed acute hypoxemic respiratory failure secondary to COVID-19 pneumonia later complicated by right upper lobe PE with pulmonary hemorrhage and superimposed VAP and associated E. coli bacteremia. Reaction classified as severe as death occurred following vaccination.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Superinfection
Clinical narrative: Narrative:  71 yo M, received dose #1 of the Moderna COVID-19 vaccine on 3/2/2021 (Lot#: 001A21A; Exp Date: 08/16/2021). On 02/26/2021, patient reported symptoms including SOB, malaise, myalgia, nausea, hematuria, and L flank pain. Patient called health care system on 3/1/2021 to inquire if patient may receive COVId-19 vaccine when he has a UTI. On 3/2/2021, nurse documented that patient denied COVID-related symptoms. Received dose #1 Moderna COVID-19 vaccine on 3/2/2021. On 3/3/2021, patient presented to emergency department due to worsening symptoms and tested positive for COVID-19 and subsequently admitted into hospital. Patient received convalescent plasma on 3/3/2021. Throughout hospital course, patient developed acute hypoxemic respiratory failure secondary to COVID-19 pneumonia later complicated by right upper lobe PE with pulmonary hemorrhage and superimposed VAP and associated E. coli bacteremia. Reaction classified as severe as death occurred following vaccination.